IIM
Ipswich Investment Management Portfolio holdings
AUM
$414M
This Quarter Return
+3.71%
1 Year Return
+15.04%
3 Year Return
+70.41%
5 Year Return
+132.95%
10 Year Return
+315.52%
AUM
$313M
AUM Growth
+$313M
(+2.4%)
Cap. Flow
-$2.38M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
27.72%
Holding
182
New
6
Increased
44
Reduced
71
Closed
7
Top Buys
| 1 |
Guardant Health
GH
|
$1.49M |
| 2 |
Watsco
WSO
|
$1.05M |
| 3 |
Lockheed Martin
LMT
|
$987K |
| 4 |
Dow Inc
DOW
|
$579K |
| 5 |
Walt Disney
DIS
|
$462K |
Top Sells
| 1 |
DuPont de Nemours
DD
|
$1.76M |
| 2 |
Regenxbio
RGNX
|
$1.67M |
| 3 |
Biogen
BIIB
|
$517K |
| 4 |
RTN
Raytheon Company
RTN
|
$504K |
| 5 |
Microsoft
MSFT
|
$419K |
Sector Composition
| 1 | Healthcare | 16.49% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 13.37% |
| 4 | Industrials | 12.39% |
| 5 | Financials | 12.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alphabet (Google) Class A
GOOGL
$2.57T
| $4.15M | 1.32% |
3,832
-34
| -0.9% | -$36.8K |
|
27
Accenture
ACN
$162B
| $4.11M | 1.31% |
22,220
+18
| +0.1% | +$3.33K |
|
28
3M
MMM
$82.8B
| $3.98M | 1.27% |
22,929
-325
| -1% | -$56.3K |
|
29
Texas Instruments
TXN
$184B
| $3.71M | 1.18% |
32,291
-510
| -2% | -$58.5K |
|
30
GSK
GSK
$79.9B
| $3.61M | 1.15% |
90,197
+6,760
| +8% | +$271K |
|
31
PepsiCo
PEP
$204B
| $3.44M | 1.1% |
26,263
| – | – |
|
32
Marsh & McLennan
MMC
$101B
| $3.43M | 1.09% |
34,373
-390
| -1% | -$38.9K |
|
33
Illinois Tool Works
ITW
$77.1B
| $3.21M | 1.03% |
21,314
+280
| +1% | +$42.2K |
|
34
Church & Dwight Co
CHD
$22.7B
| $3.21M | 1.02% |
43,867
-599
| -1% | -$43.8K |
|
35
Linde
LIN
$224B
| $3.17M | 1.01% |
15,790
-345
| -2% | -$69.3K |
|
36
Abbott
ABT
$231B
| $3.07M | 0.98% |
36,555
| – | – |
|
37
Baxter International
BAX
$12.7B
| $2.84M | 0.91% |
34,720
-395
| -1% | -$32.4K |
|
38
Citizens Financial Group
CFG
$22.6B
| $2.81M | 0.9% |
79,490
+8,105
| +11% | +$287K |
|
39
AbbVie
ABBV
$372B
| $2.76M | 0.88% |
38,000
+1,315
| +4% | +$95.6K |
|
40
Novartis
NVS
$245B
| $2.68M | 0.86% |
29,363
| – | – |
|
41
EOG Resources
EOG
$68.2B
| $2.64M | 0.84% |
28,345
-2,073
| -7% | -$193K |
|
42
McDonald's
MCD
$224B
| $2.47M | 0.79% |
11,893
| – | – |
|
43
Duke Energy
DUK
$95.3B
| $2.43M | 0.78% |
27,532
-250
| -0.9% | -$22.1K |
|
44
Thermo Fisher Scientific
TMO
$186B
| $2.28M | 0.73% |
7,773
+35
| +0.5% | +$10.3K |
|
45
Coca-Cola
KO
$297B
| $2.27M | 0.72% |
44,572
+5,100
| +13% | +$260K |
|
46
Emerson Electric
EMR
$74.3B
| $2.21M | 0.7% |
33,050
+90
| +0.3% | +$6.01K |
|
47
CRISPR Therapeutics
CRSP
$4.71B
| $2.08M | 0.66% |
44,060
-95
| -0.2% | -$4.47K |
|
48
Colgate-Palmolive
CL
$67.9B
| $2.04M | 0.65% |
28,433
-441
| -2% | -$31.6K |
|
49
AT&T
T
$209B
| $2.01M | 0.64% |
60,109
+1
| +0% | +$34 |
|
50
IBM
IBM
$227B
| $1.95M | 0.62% |
14,154
-43
| -0.3% | -$5.93K |
|